Naphtho[1,2-b]
furan-4,5-dione (
NFD), prepared from
2-hydroxy-1,4-naphthoquinone and
chloroacetaldehyde in an efficient one-pot reaction, exerts an anti-
tumor effect. This study was performed to elucidate whether the
epidermal growth factor (
EGF) receptor and phosphatidylinositol-3-kinase (PI3K) signaling pathways are involved in
NFD-induced apoptosis of
oral squamous cell carcinoma (OSCC). Immunoblot showed that
NFD suppressed the phosphorylation of
EGF receptor and activation of PI3K/Akt, downstream molecules of
EGF receptor signaling pathway, in Ca9-22 cells. The levels of downstream targets of Akt, including phospho-
glycogen synthase kinase-3beta (p-GSK-3beta),
GSK-3beta,
forkhead transcription factor (FKHR), and
cyclin D1, were also reduced after
NFD treatment. Moreover, inactivation of
nuclear factor-kappaB (
NF kappaB), modulation of I kappa K beta and I kappaB alpha, up-regulation of Bad, and down-regulation of
anti-apoptotic proteins including phospho-Bad, Bcl-X(L), myeloid cell leukemia-1(Mcl-1), and XIAP were found in
NFD-treated cells. In addition,
NFD treatment disrupted mitochondrial membrane potential (Delta Psi m), resulted in release of
cytochrome c, and activation of both caspases-9 and
caspase-3. Taken together, these results indicate that
NFD induces apoptosis in Ca9-22 cells via inactivation of the
EGF receptor-mediated survival pathway.